Sign in
  • R&D
  • Clinical
  • Commercial
    • Brand & Marketing
  • Technology
  • Insights
  • Podcast
  • Awards
    • LSV Top Industry Leaders Award 2025 Winners
    • Rising Stars Award 2026 Nomination
  • More
    • Manufacturing
    • Regulatory
    • Editorial
Sign in
Welcome!Log into your account
Forgot your password?
Privacy Policy
Password recovery
Recover your password
Search
LogoLifeNewsLife Science
LogoFashion Trends and Culture
  • R&D
    • Research & Development

      Early research shows that Lilly’s Verve strategy is successful in lowering cholesterol

      June 2, 2026
      Research & Development

      Kailera Details Nasdaq IPO Plans to Raise Up to $528.5 Million for Obesity Drug Development

      April 18, 2026
      Research & Development

      Avalyn Files for IPO to Fund Late-Stage Development of Inhaled Lung Disease Therapies

      April 10, 2026
      Research & Development

      Merck Pays $20 Million Upfront to Access Quotient’s Somatic Genomics Platform for IBD Research

      April 1, 2026
  • Clinical
    • Clinical

      Phase 3 KRYSTAL-10 Study Fails to Meet Primary Endpoints for Krazati in Metastatic Colorectal Cancer

      July 9, 2026
      Clinical

      Kailera and Hengrui Report Phase 3 Results for Oral GLP-1 Drug in Obesity and Type 2 Diabetes

      July 9, 2026
      Clinical

      Phase 3 NSCLC study for Pfizer’s first novel ADC from the acquisition of Seagen fails

      July 3, 2026
      Clinical

      BridgeBio Advances Attruby Launch and Three Late-Stage Drug Programs as It Secures New Investment

      July 3, 2026
  • Commercial
    • AllBrand & Marketing
      Commercial

      Novartis Set to Buy UK Biotech Myricx For Over $1.1B

      July 9, 2026
      Commercial

      In its biggest-ever transaction, Vertex pays $10 billion to buy endocrine disease expert Crinetics

      July 9, 2026
      Commercial

      Orca Bio Gets FDA Green Light For Tregzi; IPO a Real Possibility

      July 3, 2026
  • Technology
    • Technology

      Alnylam Inks $2B Agreement With Inceptive to Change sIRNA Design With AI Leader

      June 9, 2026
      Technology

      Chugai and Gero Partner to Develop Antibodies for Age-Related Diseases Using AI

      July 7, 2025
      Technology

      J&J MedTech presents the first Ottava surgical robot clinical cases

      April 17, 2025
      Commercial

      Wisp Launches Weight Care Vertical for Women with Hormonal Imbalances

      October 23, 2024
  • Insights
    • Insights

      The Rise of AI-Native Biotech Companies

      July 9, 2026
      Insights

      Why Every Pharma Company Is Becoming a Technology Company

      July 9, 2026
      Insights

      Top 10 Reasons Precision Medicine Requires Better Data Integration

      July 3, 2026
      Insights

      Why Pharma Supply Chains Need a Resilience-First Strategy

      July 3, 2026
  • Podcast
  • Awards
    • LSV Top Industry Leaders Award 2025 Winners
    • Rising Stars Award 2026 Nomination
  • More
    • Manufacturing
    • Regulatory
    • Editorial
type here...
Facebook
Linkedin
X
Home Tags Israel

Tag: Israel

NRx Pharmaceuticals | signs deal | homegrown | Covid-19 vaccine| 2021
Clinical

NRx Pharmaceuticals signs deal for clinical trials of Israel’s homegrown Covid-19 vaccine

Editorial Team -
July 20, 2021
0
12Page 1 of 2

Editor Picks

Roche Reports Promising Early Data on Alzheimer’s Drug Trontinemab

April 4, 2025

Flynn Pharma and Pfizer fined 70M pounds for substantial price jump on epilepsy drug

July 23, 2022

Lilly’s Plan to Build $3B Dutch Plant Underway, 500 Hires Also in the Pipeline

November 4, 2025

Must Read

The Rise of AI-Native Biotech Companies

July 9, 2026

Why Every Pharma Company Is Becoming a Technology Company

July 9, 2026

Novartis Set to Buy UK Biotech Myricx For Over $1.1B

July 9, 2026

Hot Topics

  • Clinical472
  • Commercial416
  • Regulatory338
  • Insights127
  • Research & Development106
  • Manufacturing93
  • Newsletter59
  • Technology41
Logo

About Us

Life Sciences Voice is the leading resource for life sciences executives to get crucial insights, explore the latest innovations, and learn about industry trends. Life Sciences Voice provides the community with thought-provoking commentary in multiple formats covering a range of issues from drug discovery to commercial success.

Contact us: reachout(at)lifescivoice.com

Follow Us

Facebook
Instagram
Linkedin
X

© Copyright - Life Sciences Voice

  • R&D
  • Clinical
  • Commercial
  • Technology
  • Insights
  • Podcast
  • Awards
    • LSV Top Industry Leaders Award 2025 Winners
    • Rising Stars Award 2026 Nomination
  • More
    • Manufacturing
    • Regulatory
    • Editorial